contact us

about the name

Skip to content
Golgi Neurosciences
Golgi Neurosciences
  • About us
  • The Team
  • Portfolio Companies
  • Partnering projects
  • News
  • Contact us
  • About the name

golgi_usr

Golgi Neurosciences partners with CDD Vault to Drive Innovation in Neurodegenerative Disease Treatment 

14 November 202329 August 2023 by golgi_usr

Golgi Neurosciences is pleased to announce the adoption of Collaborative Drug Discovery’s CDD Vault as unique platform for managing its drug discovery data, which will enable a more efficient research and development.

Categories Golgi News

Golgi Neurosciences and Breye Therapeutics announce successful closing of P2X7 receptor antagonist program transfer

14 November 202325 July 2023 by golgi_usr

Golgi Neurosciences and Breye Therapeutics are thrilled to announce a collaboration to advance development of innovative oral small molecule therapeutics for retinal disorders.

Categories Golgi News

About us

Golgi Neurosciences is a company-creator boutique with one ambitious mission: setting the ground to create therapies for the treatment of devasting neurodegenerative diseases by applying rigorously “Grounded Objectives Leading to a Great Impact (GOLGI)”.

The team

Portfolio companies

Partnering projects

About the name

NEWS

Golgi Neurosciences S.r.l.

Kunzi Campus - via Ariosto, 19
20091 Bresso (Milan, Italy)
Share capital: 430.815 euro
C.F./P.IVA/VAT: 12596130968
Numero REA: MI-2671780

CONTACT US

Copyright © 2026 Golgi Neurosciences. All rights reserved | Privacy Policy | Cookie Policy | Disclaimer

This website or its third party tools use cookies, which are necessary to its functioning and required for the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the cookie policy.